Skip to main content
Premium Trial:

Request an Annual Quote

RXi to Raise $7.3M in Stock, Warrant Offering

Premium

RXi Pharmaceuticals said this week that it has priced an underwritten public offering of 6 million units of stock and warrants at $1.35 apiece. The company said it expects to net $7.3 million through the transaction.

Each unit consists of one share of common stock, a 13-month warrant to buy a half a share at $1.70, and a 15-month warrant to buy half a share at $1.87.

Proceeds of the offering, which is expected to close this week, will be used for general corporate purposes, RXi said.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.